Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–30.

PubMed  Article  Google Scholar 

Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

CAS  PubMed  Article  Google Scholar 

Siewert JR, Lordick F, Ott K, Stein HJ, Weber WA, Becker K, et al. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome. Ann Surg. 2007;246:624–8 discussion 628-31.

PubMed  Article  Google Scholar 

Alderson D, Cunningham D, Nankivell M, Blazeby JM, Griffin SM, Crellin A, et al. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Lancet Oncol. 2017;18:1249–60.

CAS  PubMed  PubMed Central  Article  Google Scholar 

van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.

PubMed  Article  Google Scholar 

Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393:1948–57.

PubMed  Article  Google Scholar 

Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al. Survival for oesophageal, stomach and small intestine cancers in 1999-2007: from -5. Eur J Cancer. 2015;51:2144–57.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Philips S, Powell M, et al. Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC Cancer. 2011;11:176.

PubMed  PubMed Central  Article  Google Scholar 

Fields RC, Strong VE, Gonen M, Goodman KA, Rizk NP, Kelsen DP, et al. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer. 2011;104:1840–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rufini A, Melino G. Cell death pathology: the war against cancer. Biochem Biophys Res Commun. 2011;414:445–50.

CAS  PubMed  Article  Google Scholar 

Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726–34.

CAS  PubMed  Article  Google Scholar 

Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120:237–48.

CAS  PubMed  Article  Google Scholar 

Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer. 2007;7:961–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009;9:691–700.

CAS  PubMed  Article  Google Scholar 

Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 2007;110:313–22.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007;21:1621–35.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Crowley LC, Elzinga BM, O’Sullivan GC, McKenna SL. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol. 2011;86:38–47.

CAS  PubMed  Article  Google Scholar 

Amaravadi RK. Autophagy-induced tumor dormancy in ovarian cancer. J Clin Invest. 2008;118:3837–40.

CAS  PubMed  PubMed Central  Google Scholar 

Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007;14:500–10.

CAS  PubMed  Article  Google Scholar 

O’Donovan TR, O’Sullivan GC, McKenna SL. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy. 2011;7:509–24.

PubMed  PubMed Central  Article  Google Scholar 

Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007;14:548–58.

CAS  PubMed  Article  Google Scholar 

Bhat P, Kriel J, Shubha Priya BS, Shivananju NS, Loos B. Modulating autophagy in cancer therapy: advancements and challenges for cancer cell death sensitization. Biochem Pharmacol. 2018;147:170–82.

CAS  PubMed  Article  Google Scholar 

Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. Febs J. 2011;278:403–13.

CAS  PubMed  Article  Google Scholar 

White EJ, Martin V, Liu JL, Klein SR, Piya S, Gomez-Manzano C, et al. Autophagy regulation in cancer development and therapy. Am J Cancer Res. 2011;1:362–72.

CAS  PubMed  Google Scholar 

El-Mashed S, O’Donovan TR, Kay EW, Abdallah AR, Cathcart MC, O’Sullivan J, et al. LC3B globular structures correlate with survival in esophageal adenocarcinoma. BMC Cancer. 2015;15:582.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med. 2012;10:51.

PubMed  PubMed Central  Article  Google Scholar 

Green DR. Apoptotic pathways: ten minutes to dead. Cell. 2005;121:671–4.

CAS  PubMed  Article  Google Scholar 

Opzoomer JW, Sosnowska D, Anstee JE, Spicer JF, Arnold JN. Cytotoxic chemotherapy as an immune stimulus: a molecular perspective on turning up the immunological heat on cancer. Front Immunol. 2019;10:1654.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Linder S, Olofsson MH, Herrmann R, Ulukaya E. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert Rev Mol Diagn. 2010;10:353–9.

CAS  PubMed  Article  Google Scholar 

Fareed KR, Soomro IN, Hameed K, Arora A, Lobo DN, Parsons SL, et al. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy. World J Gastroenterol. 2012;18:1915–20.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Adams O, Dislich B, Berezowska S, Schlafli AM, Seiler CA, Kroll D, et al. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas. Oncotarget. 2016;7:39241–55.

PubMed  PubMed Central  Article  Google Scholar 

Adams O, Janser FA, Dislich B, Berezowska S, Humbert M, Seiler CA, et al. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas, vol. 13; 2018. p. e0197610.

Google Scholar 

Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJP, Harris AL, et al. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol. 2010;176:2477–89.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sivridis E, Giatromanolaki A, Liberis V, Koukourakis MI. Autophagy in endometrial carcinomas and prognostic relevance of “stone-like” structures (SLS): What is destined for the atypical endometrial hyperplasia? Autophagy. 2011;7:74–82.

CAS  PubMed  Article  Google Scholar 

Karpathiou G, Sivridis E, Koukourakis MI, Mikroulis D, Bouros D, Froudarakis ME, et al. Light-Chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 2011;140:127–34.

PubMed  Article  Google Scholar 

Sivridis E, Giatromanolaki A, Karpathiou G, Karpouzis A, Kouskoukis C, Koukourakis MI. LC3A-positive “stone-like” structures in cutaneous squamous cell carcinomas. Am J Dermatopathol. 2011;33:285–90.

PubMed  Article  Google Scholar 

Sivridis E, Koukourakis MI, Mendrinos SE, Touloupidis S, Giatromanolaki A. Patterns of autophagy in urothelial cell carcinomas-the significance of “stone-like” structures (SLS) in transurethral resection biopsies; 2013. https://doi.org/10.1016/j.urolonc.2011.12.016.

Book  Google Scholar 

Giatromanolaki A, Koukourakis MI, Harris AL, Polychronidis A, Gatter KC, Sivridis E. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol. 2010;63:867–72.

PubMed